A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
National Cancer Institute (NCI)
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
SciTech Development, Inc.
Thomas Jefferson University
Washington University School of Medicine
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
4SC AG
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
University of Wisconsin, Madison
University of Wisconsin, Madison
Virginia Commonwealth University
Northwestern University
Northwestern University
Mayo Clinic
Case Comprehensive Cancer Center
Swiss Cancer Institute
City of Hope Medical Center
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
Massachusetts General Hospital
University of Louisville
Alliance for Clinical Trials in Oncology
Progen Pharmaceuticals
Morphotek
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)